-
3 Formulations and APIs, Chronic Therapy Brands and Fermentation Ingredients Stocks With a Strong Future Roadmap: Ipca Laboratories, Eris Lifesciences and Concord Biotech
- October 21, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
No Comments
Mid-cap Pharma Growth Stocks with a strong future roadmap: Ipca Laboratories, Eris Lifesciences and Concord Biotech. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Sterile Injectables, Chronic Care Brands and Biologics Maker Stocks With a Strong Future Roadmap: Gland Pharma, Eris Lifesciences and Shilpa Medicare
- October 21, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Injectable and Specialty Pharma Stocks with a strong future roadmap: Gland Pharma, Eris Lifesciences and Shilpa Medicare. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Global Pharma Major, Chronic Care Brands and Nutrition Ingredients Stocks With a Strong Future Roadmap: Lupin, Eris Lifesciences and Sudeep Pharma
- October 21, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Pharma Portfolio Stocks with a strong future roadmap: Lupin, Eris Lifesciences and Sudeep Pharma. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Drug Discovery Services, Branded Formulations and Contract Manufacturing Stocks With a Strong Future Roadmap: Sai Life Sciences, Eris Lifesciences and Innova Captab
- October 21, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Pharma Services Stocks with a strong future roadmap: Sai Life Sciences, Eris Lifesciences and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.